2023 IHEA pre-congress presentations

Day 1: Saturday July 8

08.30-09.30

Welcome, introduction to the community of practice & overview of existing evidence and tools

A brief overview of the Immunization Economics community of practice

Logan Brenzel, Independent Consultant

Objectives of the pre-congress meeting and overview of the agenda

Laura Boonstoppel, ThinkWell

Findings from a systematic review of new vaccine introduction cost projects

Ann Levin, Levin & Morgan

Overview of new and existing costing tools

Winthrop Morgan, Levin & Morgan

09.30-10.40

Evidence from bottom-up costing studies vs. modeled estimates: What have we learned from COVID-19 vaccine delivery costing?

Lessons from the COVAX global delivery cost model

Ibironke Oyatoye, UNICEF

The cost of delivering COVID-19 vaccines in six countries

Flavia Moi, ThinkWell

The cost of delivering COVID-19 vaccines in Malawi

Anika Ruisch, Management Sciences for Health

Evidence from bottom-up costing studies vs. modeled estimates: What have we learned from COVID-19 vaccine delivery costing?

Karene Hoi Ting Yeung, WHO

11.00-12.00

Immunization financing: Traditional vaccines & budget execution

Financial sustainability of traditional vaccines

Brendan Kwesiga, UNICEF

Tracking immunization budget credibility in Ghana: The case of five metropolitan, municipal, and district assemblies

Emmanuel Ayifah, SEND Ghana

Increasing expenditures for operational costs in DRC and Nigeria

Grace Chee, JSI

13.00-14.00

Breakout A: Driving development and introduction based on full value of vaccine assessments

Driving development and introduction based on full value of vaccine assessments (FVVA)

Philipp Lambach (WHO), JP Sevilla (Harvard T.H. Chan School of Public Health) and Allison Portnoy (Boston University)

View presentation

13.00-14.00

Breakout B: Driving development and introduction based on full value of vaccine assessments

Priority setting of available vaccines and vaccine innovations

Raymond Hutubessy, WHO

View presentation

15.30-16.30

Plenary discussion: collaborating as a community of practice

Plenary discussion: Collaborating as a community of practice

Logan Brenzel (Independent Consultant), Sarah Pallas (U.S. CDC), Ulla Griffiths (UNICEF), Todi Mengistu (Gavi) and Raymond Hutubessy (WHO)

View discussion

Day 2: Sunday July 9

08.45-10.00

Immunization financing: Donor transitions, sustainability & integration

Global survey: Integrating the COVID-19 vaccine into existing services & targeting priority populations

Damian Walker, Management Sciences for Health

Supporting decision-making on programmatic and financial sustainability at different stages of Gavi transition in Laos, Nigeria, and Kenya

Sebastian Ilomuanya, Praveena Gunaratnam, Faith Mutuku, Victoria Wanjohi, Kikelomo Lambo and Sima Unogu, CHAI

10.15-11.15

Next questions in costing and modeling methods

Next questions in costing and modeling methods

Sarah Pallas (U.S. CDC), Roopa Darwar (U.S. CDC), Sachiko Ozawa (University of North Carolina at Chapel Hill) and Rachel Hounsell (University of Oxford)

View presentation

11.15-12.15

Breakout A: Methods and practical challenges in costing HPV and malaria vaccine programs

Methods and practical challenges in costing HPV and malaria vaccine programs

Mercy Mvundura, Rose Slavkovsky and Ranju Baral, PATH

View presentation

11.15-12.15

Breakout B: Health Technology Assessment of COVID-19 vaccination in Nigeria

Health Technology Assessment of COVID-19 vaccination in Nigeria

Benjamin Uzochukwu (University of Nigeria, Nsukka), Chinyere Okeke (University of Nigeria, Nsukka) and Sergio Torres Rueda (London School of Hygiene and Tropical Medicine)

View presentation

13.15-14.45